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INTRODUCTION
The proportion of patients with acute coronary syndrome (ACS) who 
are very old is increasing. The care of the elderly patients is more 
complex than that of younger. The older patients are a therapeutic
challenge because they are rarely included in randomized clinical 
trials. 
PURPOSE
Determine clinical presentation, therapeutic approach and prognosis 
in a population of octogenarians (Oct) with ACS
METHODS
 Retrospective study of 2064 patients admitted for ACS in a 
coronary unit over a period of 4 years
 2 groups were defined according to age: younger (age < 80 years) 
and Oct (age ≥ 80 years)
 Analysis of Oct according to therapeutic approach: 
percutaneous/surgical (n = 177) vs medical (n = 92)
 Minimal follow-up of six months
RESULTS
CONCLUSION
In this review, the elderly had worse prognosis and were less likely to receive evidence-based therapy. Although mortality was higher in 
octogenarians patients under medical treatment, the absence of revascularization was not an independent predictor of mortality in this 
population.
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Killip class ≥ 2 on admission 3.6 (1.3-9.8)
Left ventricular dysfunction 6.0 (1.1-31.1)
GFR ≤ 60ml/min 5.9 (1.9-18)
Table 1 – Baseline patients characteristics
LVEF = left ventricular ejection fraction, NSTEMI = non ST elevation myocardial infarction, SD = 
standard deviation. 
Table 2 – In-hospital treatment
ACE = angiotensin converting enzyme, ARB2 = angiotensin II receptor blockers, CABG = coronary artery
bypass grafting, PCI = percutaneous coronary intervention.
p <0.001


















In a sub-analysis of Oct there were no significant differences in the demographic characteristics.
Myocardial infarction without ST segment elevation is more common in Oct non revascularized (73.6%
vs 39.5%, p <0.001).
The Oct non revascularized had the highest prevalence of Killip class ≥ 2 on admission (52.7% vs
40.1%, p = 0.049) and moderate to severe left ventricular dysfunction (56.1% vs 42%, p = 0.034).









































Figure 2 In-hospital mortality (A) and survival analysis by Kaplan-Meier curves, according to the therapeutic 
approach (B).
After multivariate analysis, the absence of revascularization was not a predictor of mortality. 
Table 3 – Independent predictors of in-hospital mortality 
OR (IC95%)
Left ventricular dysfunction 2.5 (1.1-6.0)
In-hospital heart failure 3.6 (1.6-7.9)
Absence of beta-blocker therapy 3.6 (1.6-7.9)
Table 4 – Independent predictors of mortality at 6 months
Oct non revascularized
Oct revascularized
Log rank = 0.046
